...5/02 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE(CHMP) NOTE FOR GUIDANCE ON THE EVALUATION OF THEPHARMACOKINETICS OF MEDICINAL PRODUCTS IN PATIENTSWITH IMPAIRED RENAL FUNCTION DISCUSSION IN THE EFFICACY WORKING PA...
...hic Science, Vol. 43, April 2005Determination of Nifuratel in Human Plasma by HPLC and Study on Its PharmacokineticsYanwei Wu, Bingren Xiang*, Jin Yang, Jingjuan Fu, andJianhua JiangChina Pharmaceutical University, C...
Effectofomeprazoleonthepharmacokineticsandtoxicitiesofirinotecanincancerpatients:Aprospectivecross-overdrug–druginteractionstudy5JessicaM.v...
2238Biol. Pharm. Bull.30(12) 2238—2243 (2007)Vol. 30, No. 12Population Pharmacokinetics and Proton Pump Inhibitory Effects ofIntravenous Lansoprazole in Healthy Japanese MalesYuichi SAKUR...
...: 0377-8282/2013DOI: 10.1358/dof.2013.38.4.1906426THOMSON REUTERSREVIEW ARTICLETHE ROLE OF OATPS IN PHARMACOKINETICSAND DRUG–DRUG INTERACTIONS OF CARDIOVASCULAR AGENTSJ.H. Wen1, W. Wu2, D. Yang3, L.Y. Guo4, W.W. Xu5,...
JInfectChemother(2013)19:858–866DOI10.1007/s10156-013-0580-2ORIGINALARTICLEPopulationpharmacokineticsandpharmacodynamicsofsita oxacininpatientswithcommunity-acquiredrespiratorytractinfectionsYusukeTani...
November 2007Biol. Pharm. Bull.30(11) 2173—2177 (2007)2173Pharmacokinetics and Variation in the Clearance of Oxycodone andHydrocotarnine in Patients with Cancer PainHideya KO...
...Association for Laboratory Animal ScienceVol 49, No 3June 1999Effect of Respiratory Tract Disease onPharmacokinetics of Tilmicosin in RatsSanja Modric,1* A. I. Webb,1 and Maureen Davidson2Background and Purpose: In r...
REVIEWTheRoleofOATP1B1andBCRPinPharmacokineticsandDDIofNovelStatinsWenJinHua,WeiXiaoHua&HuJinFangDepartmentofPharmacy,theFirstAf liatedHospital...